ADA2 and neoplasm: Aiming to understand if an increased tumor area over time resulted from an increased proliferative capacity of BCCs, we assessed the expression of the proliferation marker, Ki-67, together with the epithelial marker, pan cytokeratin, in order to visualize metastatic lesions.